News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
387,617 Results
Type
Article (26152)
Company Profile (61)
Press Release (361400)
Multimedia
Podcasts (31)
Webinars (7)
Section
Business (104321)
Career Advice (453)
Deals (16876)
Drug Delivery (52)
Drug Development (47659)
Employer Resources (47)
FDA (12312)
Job Trends (8469)
News (186158)
Policy (19501)
Tag
Academia (1752)
Accelerated approval (6)
Adcomms (9)
Allergies (85)
Alliances (26827)
ALS (75)
Alzheimer's disease (891)
Antibody-drug conjugate (ADC) (80)
Approvals (12444)
Artificial intelligence (224)
Autoimmune disease (21)
Automation (4)
Bankruptcy (142)
Best Places to Work (6893)
BIOSECURE Act (5)
Biosimilars (50)
Biotechnology (38)
Bladder cancer (87)
Brain cancer (26)
Breast cancer (278)
Cancer (2117)
Cardiovascular disease (176)
Career advice (410)
Career pathing (13)
CAR-T (100)
CDC (24)
Cell therapy (266)
Cervical cancer (19)
Clinical research (41535)
Collaboration (602)
Compensation (210)
Complete response letters (13)
COVID-19 (1531)
CRISPR (26)
C-suite (273)
Cystic fibrosis (50)
Data (2546)
Decentralized trials (2)
Denatured (19)
Depression (54)
Diabetes (255)
Diagnostics (3596)
Digital health (15)
Diversity (6)
Diversity, equity & inclusion (13)
Drug discovery (67)
Drug pricing (74)
Drug shortages (22)
Duchenne muscular dystrophy (86)
Earnings (37871)
Editorial (25)
Employer branding (6)
Employer resources (45)
Events (52883)
Executive appointments (545)
FDA (13902)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (561)
Gene editing (53)
Generative AI (13)
Gene therapy (181)
GLP-1 (477)
Government (3117)
Grass and pollen (3)
Guidances (195)
Healthcare (12198)
HIV (30)
Huntington's disease (13)
IgA nephropathy (28)
Immunology and inflammation (60)
Immuno-oncology (2)
Indications (27)
Infectious disease (1628)
Inflammatory bowel disease (92)
Inflation Reduction Act (5)
Influenza (37)
Intellectual property (79)
Interviews (40)
IPO (7059)
IRA (22)
Job creations (1844)
Job search strategy (380)
Kidney cancer (8)
Labor market (27)
Layoffs (187)
Leadership (5)
Legal (3642)
Liver cancer (61)
Longevity (6)
Lung cancer (354)
Lymphoma (160)
Machine learning (6)
Management (17)
Manufacturing (183)
MASH (75)
Medical device (13090)
Medtech (13101)
Mergers & acquisitions (10214)
Metabolic disorders (599)
Multiple sclerosis (72)
NASH (11)
Neurodegenerative disease (71)
Neuropsychiatric disorders (12)
Neuroscience (1374)
NextGen: Class of 2025 (3931)
Non-profit (2828)
Now hiring (26)
Obesity (267)
Opinion (83)
Ovarian cancer (77)
Pain (97)
Pancreatic cancer (87)
Parkinson's disease (115)
Partnered (13)
Patents (165)
Patient recruitment (188)
Peanut (39)
People (35136)
Pharmaceutical (17)
Pharmacy benefit managers (12)
Phase I (11891)
Phase II (17971)
Phase III (14762)
Pipeline (1355)
Policy (112)
Postmarket research (1668)
Preclinical (3702)
Press Release (18)
Prostate cancer (117)
Psychedelics (22)
Radiopharmaceuticals (164)
Rare diseases (259)
Real estate (2854)
Recruiting (17)
Regulatory (14799)
Reports (18)
Research institute (1618)
Resumes & cover letters (48)
Rett syndrome (6)
RNA editing (3)
RSV (26)
Schizophrenia (84)
Series A (86)
Series B (71)
Service/supplier (3)
Sickle cell disease (29)
Special edition (5)
Spinal muscular atrophy (103)
Sponsored (15)
Startups (2126)
Stomach cancer (9)
Supply chain (47)
Tariffs (22)
The Weekly (12)
Vaccines (445)
Venture capital (16)
Weight loss (174)
Women's health (23)
Worklife (4)
Date
Today (43)
Last 7 days (207)
Last 30 days (1138)
Last 365 days (17059)
2025 (11799)
2024 (19849)
2023 (22737)
2022 (30680)
2021 (32984)
2020 (32190)
2019 (28412)
2018 (21811)
2017 (18906)
2016 (18112)
2015 (21196)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13183)
Location
Africa (360)
Alabama (25)
Alaska (2)
Arizona (135)
Arkansas (10)
Asia (24988)
Australia (3945)
California (4274)
Canada (1581)
China (561)
Colorado (216)
Connecticut (220)
Delaware (171)
Europe (48874)
Florida (740)
Georgia (178)
Idaho (35)
Illinois (459)
India (23)
Indiana (297)
Iowa (7)
Japan (192)
Kansas (81)
Kentucky (16)
Louisiana (12)
Maine (27)
Maryland (757)
Massachusetts (2934)
Michigan (123)
Minnesota (354)
Mississippi (3)
Missouri (61)
Montana (18)
Nebraska (18)
Nevada (52)
New Hampshire (65)
New Jersey (1506)
New Mexico (9)
New York (1238)
North Carolina (674)
North Dakota (4)
Northern California (1900)
Ohio (168)
Oklahoma (6)
Oregon (24)
Pennsylvania (1076)
Puerto Rico (9)
Rhode Island (30)
South America (521)
South Carolina (40)
Southern California (1686)
Tennessee (102)
Texas (764)
United States (17022)
Utah (152)
Virginia (114)
Washington D.C. (47)
Washington State (281)
West Virginia (4)
Wisconsin (49)
387,617 Results for "reflexion medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
CMS Assigns Accretive Reimbursement for RefleXion’s Breakthrough SCINTIX Therapy
RefleXion Medical, Inc. announced that the Centers for Medicare and Medicaid Services has established a national payment rate for RefleXion’s SCINTIX® biology-guided radiotherapy using CMS’ New Technology Ambulatory Payment Classification pathway.
January 11, 2024
·
4 min read
RefleXion and Limbus AI Announce Technology Integration to Expedite Cancer Treatment Planning
RefleXion Medical, Inc. and Limbus AI, Inc. announced a licensing agreement to incorporate Limbus’ automated contouring software, Limbus Contour, into the RefleXion® X1 radiotherapy treatment planning system.
March 28, 2024
·
4 min read
Biotech Bay
RefleXion to Present at 2024 Jeffries Global Healthcare Conference
RefleXion Medical, Inc. today announced that Todd Powell, president and chief executive officer, Sam Mazin, Ph.D., founder and chief technology officer, and Sean Shirvani, M.D., chief medical officer will present an overview of the company and its breakthrough SCINTIX biology-guided radiotherapy at the Jeffries Global Healthcare Conference on Wednesday, June 5 at 8:30 a.m. EDT.
June 4, 2024
·
1 min read
Press Releases
RefleXion Launches Pivotal Study to Expand SCINTIX Therapy and Announces Broader Medicare Reimbursement
January 8, 2025
·
2 min read
Biotech Bay
World’s First Cancer Patient Treated with RefleXion’s Breakthrough SCINTIX Biology-guided Radiotherapy
RefleXion Medical, a therapeutic oncology company, today announced that the first patient has completed treatment with SCINTIX™ biology-guided radiotherapy on the RefleXion® X1 machine at the Stanford Medicine Cancer Center.
August 23, 2023
·
4 min read
Biotech Bay
RefleXion Announces Initial Close of $105M Fundraising to Commercialize New Cancer Treatment
RefleXion Medical, a therapeutic oncology company, today announced the initial closing of a $105M equity raise, led by The Rise Fund, TPG’s multi-sector global impact investing strategy.
November 15, 2023
·
2 min read
Biotech Bay
RefleXion Showcases Breakthrough SCINTIX Biology-Guided Radiotherapy and Highlights New Research at ASTRO 2023 Meeting
RefleXion® Medical, a therapeutic oncology company, today announced the company will showcase the RefleXion® X1 with SCINTIX™ biology-guided radiotherapy at the American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 1-4, 2023 in San Diego (booth #2831).
September 28, 2023
·
4 min read
Biotech Bay
RefleXion Announces 28 Scientific Presentations at the AAPM 2023 Annual Meeting
RefleXion Medical, a therapeutic oncology company, today announced that researchers from multiple clinical programs will present new scientific evidence in 28 oral, panel, and poster presentations validating the efficacy and feasibility of the RefleXion® X1 machine with SCINTIX™ biology-guided radiotherapy at the 2023 American Association of Physicists in Medicine (AAPM) Annual Meeting in Houston, July 23-26.
July 20, 2023
·
4 min read
Biotech Bay
RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharmaceuticals to Treat High Unmet Need Cancers Including Brain, Pancreatic and Liver
RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for cancer detection and treatment, announced an exclusive licensing agreement for RefleXion to develop and commercialize a specific 3BP molecule to direct its SCINTIX™ biology-guided radiotherapy.
September 20, 2023
·
4 min read
Biotech Bay
RefleXion Highlights Clinical Study Results for Future Prostate Cancer Treatment
RefleXion Medical, Inc. today announced that results of a prospective investigator-initiated clinical imaging study conducted on its X1 platform by City of Hope using positron emission tomography (PET) were presented on June 24 during an oral session at the Society of Nuclear Medicine and Medical Imaging (SNMMI) annual meeting in Chicago.
June 26, 2023
·
4 min read
1 of 38,762
Next
